Cresset Group
Harnessing AI and machine learning methods, the company's state-of-the-art in-silico (i.e., computer-simulated) solutions for drug discovery optimise chemistry R & D innovation and efficiency and accelerate better treatment development for humans, animals and the environment.
Eight top ten pharmaceutical companies globally use Cresset's computer-aided drug discovery (CADD) solutions. The company has just strengthened its senior leadership team by recruiting Dr Mutlu Dogruel from Microsoft as VP for AI Solutions, an indicator of how much progress Cresset is making in providing solutions for CADD, DMTA efficiency and contract research worldwide.
The company extended its US presence with a new facility in the Greater Boston area in March 2024 and opened a base in Bangalore in May.
